Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods

被引:30
|
作者
Bertrand, Dominique [1 ,2 ]
Pallet, Nicolas [2 ,3 ]
Sartorius, Albane [1 ,2 ]
Zahar, Jean Ralph [2 ,4 ]
Soussan, Rebecca Sberro [1 ,2 ]
Lortholary, Olivier [2 ,5 ]
Legendre, Christophe [1 ,2 ]
Mamzer, Marie-France [1 ,2 ]
机构
[1] Hop Necker Enfants Malad, Serv Transplantat Renale & Soins Intensifs, Paris, France
[2] Univ Paris 05, Paris, France
[3] Hop Europeen Georges Pompidou, Serv Nephrol, F-75015 Paris, France
[4] Hop Necker Enfants Malad, Microbiol Serv, Paris, France
[5] Hop Necker Enfants Malad, Serv Malad Infect, Paris, France
关键词
allograft; bacterial contamination; infection; Kidney; preservation fluid; INFECTIONS; FLUID; DONOR;
D O I
10.1111/tri.12130
中图分类号
R61 [外科手术学];
学科分类号
摘要
The clinical and bacteriological consequences of routinely performing highly sensitive bacterial screening of kidney transplant preservation solution (PS) are not known. To evaluate the clinical and microbiological impacts of this strategy, we retrospectively analyzed 200 consecutive kidney allograft recipients from March 2009 to February 2011 for whom PS samples were routinely screened. PS were inoculated into aerobic and anaerobic blood culture bottles, as well as blood agar plates. A rectal swab for extended-spectrum -lactamase-producing Enterobacteriaceae (EBSL-PE) faecal carriage was also routinely obtained from each patient at admission and every 7days until hospital discharge. In addition, a standard culture of drain fluid was collected on the day after kidney transplantation. Complete samples and cultures of PS were performed in 165 cases (82.5%), and 62 (37.6%) had positive blood culture results. The most frequent microbial agent isolated was coagulase-negative staphylococci (51.8%). Of these 62 positive samples, only seven (11.3%) were confirmed to contain the same organism by the standard culture method. Drain fluid and PS culture positivity with the same microorganism occurred in only two patients. Of the 62 patients with positive PS cultures, 26 (41.9%) received pre-emptive antibiotic therapy initiated within 48h post-transplant. During the hospitalization period, patients with a positive PS culture, regardless of whether they received pre-emptive antibiotic therapy, did not exhibit any invasive infections (urinary, blood, peritoneal or wound) related to the microorganisms isolated in the PS. Patients with positive PS cultures who were treated with antibiotic therapy acquired significantly more colonizing ESBL-PE than patients who did not receive antibiotics (53.8% vs. 16.6%; P=0.01); these patients also developed more clinical infections related to the ESBL-PE (23.1% vs. 5.2%; P<0.01). The use of antibiotics for patients with positive PS cultures was an independent risk factor for ESBL-PE acquisition in both univariate and multivariate analyses. In conclusion, the use of more sensitive culture methods increases the rate of bacterial contamination of PS and is associated with an increased prescription of antibiotics and increased ESBL-PE carriage and related infections. Therefore, the systematic use of PS blood bottle cultures in kidney transplantation may have no benefit and might increase the rate of ESBL-PE emergence.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 38 条
  • [1] Screening Kidney Allograft Preservative Fluid for Bacterial Contamination: The Perfect Is the Enemy of the Good!
    Bertrand, D.
    Zahar, J. R.
    Legendre, C.
    Mamzer-Bruneel, M. -F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 207 - 207
  • [2] CLINICAL IMPACT OF BACTERIAL CONTAMINATION OF PERFUSION FLUID IN KIDNEY TRANSPLANTATION
    Ranghino, Andrea
    Simonato, Francesca
    Quercia, Alessandro D.
    Diena, Davide
    Messina, Maria
    Tognarelli, Giuliana
    Burdese, Manuel
    Piraina, Valentina
    Segoloni, Giuseppe Paolo
    Biancone, Luigi
    TRANSPLANT INTERNATIONAL, 2013, 26 : 227 - 227
  • [3] Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation
    Ranghino, A.
    Diena, D.
    Simonato, F.
    Messina, M.
    Burdese, M.
    Piraina, V.
    Fop, F.
    Segoloni, G. P.
    Biancone, L.
    SPRINGERPLUS, 2016, 5 : 1 - 6
  • [4] AlphaCAMM, a Micromegas-based camera for high-sensitivity screening of alpha surface contamination
    Altenmuller, Konrad
    Castel, Juan F.
    Cebrian, Susana
    Dafni, Theopisti
    Diez-Ibanez, David
    Galan, Javier
    Galindo, Javier
    Antonio Garcia, Juan
    Irastorza, Igor G.
    Luzon, Gloria
    Margalejo, Cristina
    Mirallas, Hector
    Obis, Luis
    Ortiz de Solorzano, Alfonso
    Perez, Oscar
    JOURNAL OF INSTRUMENTATION, 2022, 17 (08)
  • [5] Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
    Ola, Olatunde
    Akula, Ashok
    De Michieli, Laura
    Dworak, Marshall
    Crockford, Erika
    Lobo, Ronstan
    Rastas, Nicholas
    Knott, Jonathan D.
    Mehta, Ramila A.
    Hodge, David O.
    Grube, Eric
    Karturi, Swetha
    Wohlrab, Scott
    Tak, Tahir
    Cagin, Charles
    Gulati, Rajiv
    Jaffe, Allan S.
    Sandoval, Yader
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (25) : 3160 - 3170
  • [6] HIGH-SENSITIVITY TSH ASSAY IN CLINICAL-PRACTICE - EVALUATION OF 3 METHODS
    MAZZUCA, M
    SCARPATO, F
    RUSSO, R
    FALCIANI, C
    MALVALDI, F
    SCIARRA, A
    MORINI, V
    COLI, A
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 111 - 111
  • [7] Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment A Randomized Clinical Trial
    Gallacher, Peter J.
    Miller-Hodges, Eve
    Shah, Anoop S. V.
    Anand, Atul
    Dhaun, Neeraj
    Mills, Nicholas L.
    JAMA INTERNAL MEDICINE, 2021, 181 (09) : 1237 - 1239
  • [8] High-Sensitivity Cardiac Troponin Assay in Patients With Kidney Impairment A Challenge to Clinical Implementation
    Hemmert, Keith C.
    Sun, Benjamin C.
    JAMA INTERNAL MEDICINE, 2021, 181 (09) : 1239 - 1241
  • [9] Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
    Hitsumoto T.
    Clinical Hypertension, 23 (1)
  • [10] Myocardial infarction redefined: the impact of high-sensitivity troponin testing on clinical practice
    Vinen, J.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (03) : 171 - 172